华法林使用的障碍：潜在解决方案。 - Suppr

Suppr

超能文献

Barriers to the use of warfarin: potential solutions.

作者信息

McAnulty John H

机构信息

Oregon Health & Science University, Portland, Oregon, USA.

出版信息

J Interv Card Electrophysiol. 2004;10 Suppl 1:17-20. doi: 10.1023/B:JICE.0000011341.67214.2e.

DOI:10.1023/B:JICE.0000011341.67214.2e

PMID:14739735

Abstract

摘要

相似文献

Barriers to the use of warfarin: potential solutions.华法林使用的障碍：潜在解决方案。

J Interv Card Electrophysiol. 2004;10 Suppl 1:17-20. doi: 10.1023/B:JICE.0000011341.67214.2e.

[Atrial fibrillation: new anticoagulants are more effective and safer, but expensive].

Praxis (Bern 1994). 2014 Jun 18;103(13):785-6. doi: 10.1024/1661-8157/a001681.

Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues.

Chest. 1998 Nov;114(5 Suppl):699S-714S. doi: 10.1378/chest.114.5_supplement.699s.

Quality of anticoagulation control in atrial fibrillation.心房颤动抗凝控制的质量

Lancet. 2010 Sep 18;376(9745):935-7. doi: 10.1016/S0140-6736(10)61305-0.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.伴有国际标准化比值低于治疗范围的心房颤动或机械性心脏瓣膜患者的血栓栓塞并发症发生率：一项前瞻性多中心队列研究。

Am J Hematol. 2012 Apr;87(4):384-7. doi: 10.1002/ajh.23119. Epub 2012 Feb 24.

Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.正方观点：“华法林应该是老年房颤患者血栓预防的首选药物”。为什么华法林确实应该成为老年房颤患者预防中风的首选药物。

Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.

Aniticoagulation in patients following prosthetic heart valve replacement.人工心脏瓣膜置换术后患者的抗凝治疗

Ann Thorac Cardiovasc Surg. 2009 Feb;15(1):10-7.

Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation.达比加群在减轻机械心脏瓣膜诱导的凝血酶生成方面不如华法林有效。

J Am Heart Assoc. 2015 Aug 24;4(8):e002322. doi: 10.1161/JAHA.115.002322.

Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者使用华法林治疗时发生缺血性卒中及出血并发症的风险。

Intern Med. 2001 Dec;40(12):1166-7. doi: 10.2169/internalmedicine.40.1166.

Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.反对观点：“华法林应是老年房颤患者血栓预防的首选药物”。关于老年房颤患者使用口服抗凝治疗的注意事项。

Thromb Haemost. 2008 Jul;100(1):16-7. doi: 10.1160/TH08-06-0343.

引用本文的文献

Transitions of care in anticoagulated patients.抗凝治疗患者的治疗过渡期。

J Multidiscip Healthc. 2013 Jun 20;6:215-28. doi: 10.2147/JMDH.S44068. Print 2013.

本文引用的文献

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.长期、低强度华法林治疗预防复发性静脉血栓栓塞。

N Engl J Med. 2003 Apr 10;348(15):1425-34. doi: 10.1056/NEJMoa035029. Epub 2003 Feb 24.

Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.华法林剂量减少与国际标准化比值轻度升高时的观察等待比较。

Chest. 2003 Feb;123(2):499-503. doi: 10.1378/chest.123.2.499.

Benefits of a mobile, point-of-care anticoagulation therapy management program.移动即时护理抗凝治疗管理项目的益处。

Jt Comm J Qual Improv. 2002 Nov;28(11):625-30. doi: 10.1016/s1070-3241(02)28066-9.

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.希美加群与华法林预防全膝关节置换术后静脉血栓栓塞的比较：一项随机双盲试验

Ann Intern Med. 2002 Oct 15;137(8):648-55. doi: 10.7326/0003-4819-137-8-200210150-00008.

The use of oral anticoagulants (warfarin) in older people. American Geriatrics Society guideline.老年人使用口服抗凝剂（华法林）。美国老年医学会指南。

J Am Geriatr Soc. 2002 Aug;50(8):1439-45; discussion 1446-7. doi: 10.1046/j.1532-5415.2002.50380.x.

Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.在城市周边贫困人群中，人工心脏瓣膜患者使用固定剂量与调整剂量华法林的比较。

J Heart Valve Dis. 2002 Jul;11(4):583-92; discussion 593.

Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients.自我管理的抗凝治疗：一项针对心脏瓣膜病患者的两年前瞻性随机试验结果

Ann Thorac Surg. 2001 Nov;72(5):1523-7. doi: 10.1016/s0003-4975(01)03049-1.

Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators.伴有间歇性心房颤动的卒中：阿司匹林治疗期间的发病率及预测因素。心房颤动卒中预防研究组。

J Am Coll Cardiol. 2000 Jan;35(1):183-7. doi: 10.1016/s0735-1097(99)00489-1.

Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.阿司匹林治疗期间卒中低风险的非瓣膜性心房颤动患者：心房颤动卒中预防III研究。心房颤动卒中预防研究组SPAF III写作委员会。

JAMA. 1998;279(16):1273-7.

Generic warfarin: a cost-effective alternative to brand-name drug or a clinical wild card?

Chest. 1998 Feb;113(2):261-3. doi: 10.1378/chest.113.2.261.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验